Literature DB >> 3887750

Anti-A production by a group O spleen transplanted to a group A recipient.

D J Salamon, G Ramsey, J Nusbacher, S Yang, T E Starzl, L Israel.   

Abstract

A group A1 diabetic received a pancreas-spleen transplant from a group 0 donor. Severe immune hemolysis due to anti-A ensued, requiring graft splenectomy. The transplanted spleen can be a potent source of blood group antibody.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3887750      PMCID： PMC2952502          DOI： 10.1111/j.1423-0410.1985.tb00187.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN： 0042-9007            Impact factor:   2.144


  6 in total

1.  SPLENIC HOMOTRANSPLANTATION.

Authors:  T L MARCHIORO; D T ROWLANDS; D RIFKIND; W R WADDELL; T E STARZL; H FUDENBERG
Journal:  Ann N Y Acad Sci       Date:  1964-11-30       Impact factor: 5.691

2.  Development of 'auto-anti-A1 antibodies' following alloimmunization in an A2 recipient.

Authors:  M Contreras; G R Hazlehurst; S E Armitage
Journal:  Br J Haematol       Date:  1983-12       Impact factor: 6.998

3.  Emergence of red blood cell agglutinins following renal transplantation in a patient with systemic lupus erythematosus.

Authors:  J Stevens; C O Callender; P N Jilly
Journal:  Transplantation       Date:  1981-11       Impact factor: 4.939

4.  Anti-A autoantibodies with unusual properties in a patient on renal dialysis.

Authors:  G W Bird; J Wingham
Journal:  Immunol Commun       Date:  1980

5.  Pancreaticoduodenal transplantation in humans.

Authors:  T E Starzl; S Iwatsuki; B W Shaw; D A Greene; D H Van Thiel; M A Nalesnik; J Nusbacher; H Diliz-Pere; T R Hakala
Journal:  Surg Gynecol Obstet       Date:  1984-09

6.  The course of pancreas allografts in rats conditioned by spleen allografts.

Authors:  H Bitter-Suermann; J Säve-Söderbergh
Journal:  Transplantation       Date:  1978-07       Impact factor: 4.939
  6 in total
  1 in total

1.  Isohemagglutinins of graft origin after ABO-unmatched liver transplantation.

Authors:  G Ramsey; J Nusbacher; T E Starzl; G D Lindsay
Journal:  N Engl J Med       Date:  1984-11-01       Impact factor: 91.245
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.